Effects of remifentanil versus nitrous oxide on postoperative nausea, vomiting, and pain in patients receiving thyroidectomy: Propensity score matching analysis
2016
Remifentaniland nitrous oxide (N2O) are 2 commonly used anesthetic agents. Both these agents are known risk factors for
postoperative nauseaand
vomiting(PONV). However,
remifentaniland N2O have not been directly compared in a published study.
Remifentanilcan induce acute tolerance or hyperalgesia, thus affecting postoperative pain. The objective of this retrospective study is to compare the effects of
remifentaniland N2O on PONV and pain in patients receiving intravenous
patient-controlled analgesia(IV-PCA) after
thyroidectomy. We analyzed the electronic medical records of 992 patients receiving fentanyl-based IV-PCA after
thyroidectomyat Chung-Ang University Hospital from January 1, 2010 to April 30, 2016. We categorized the patients according to anesthetic agents used: group N2O (n = 745) and group
remifentanil(n = 247). The
propensity score matchingmethod was used to match patients in the 2 groups based on their covariates. Finally, 128 matched subjects were selected from each group. There were no differences between groups for all covariates after
propensity score matching. The numeric rating scale for
nausea(0.55 ± 0.88 vs 0.27 ± 0.76, P = 0.01) was higher and complete response (88 [68.8%] vs 106 [82.8%], P = 0.001) was lower in group N2O compared with group
remifentanilon postoperative day 0. However, the visual analog scale score for pain (3.47 ± 2.02 vs 3.97 ± 1.48, P = 0.025) was higher in group
remifentanilthan group N2O on postoperative day 0. In patients receiving IV-PCA after
thyroidectomy,
postoperative nauseawas lower but postoperative pain was higher in group
remifentanil.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
34
References
7
Citations
NaN
KQI